RANCHO CORDOVA, Calif.,
Aug. 31, 2020 /PRNewswire/ --
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader
in automated cell processing tools and services in the cell and
gene therapy field, today announced management's participation in
the following investor conferences in September.
- September 1-4: LD Micro
500. Chris Xu, Ph.D., Chief
Executive Officer of ThermoGenesis, will present a company overview
at this virtual conference on Wednesday,
September 2, at 5:00 pm ET. A
live webcast of the presentation will be available on the
ThermoGenesis website at:
https://ThermoGenesis.com/investors/news-and-events/events-webcasts.
An archived replay will be available for a period of 90 days after
the conference.
- September 14-16: H.C.
Wainwright 22nd Annual Global Investment Conference.
Jeff Cauble, Chief Financial Officer
of ThermoGenesis, will present a company overview at this virtual
conference on Tuesday, September 15,
at 12:00 pm ET. A live webcast of the
presentation will be available on the ThermoGenesis website at:
https://ThermoGenesis.com/investors/news-and-events/events-webcasts.
An archive replay will be available for a period of 90 days after
the conference.
About ThermoGenesis Holdings, Inc.
ThermoGenesis
Holdings, Inc. develops, commercializes, and markets a range of
automated technologies for CAR-T and other cell-based therapies.
The Company currently markets a full suite of solutions for
automated clinical biobanking, point-of-care applications, and
automation for immuno-oncology, including its semi-automated,
functionally-closed CAR-TXpress™ platform, which streamlines
the manufacturing process for the emerging CAR-T immunotherapy
market. For more information about ThermoGenesis, please
visit: www.thermogenesis.com.
Company Contact:
Wendy Samford
916-858-5191
ir@ThermoGenesis.com
Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com
View original
content:http://www.prnewswire.com/news-releases/thermogenesis-holdings-to-participate-in-investor-conferences-in-september-301120615.html
SOURCE ThermoGenesis Holdings, Inc.